Medpace
Update in progressMEDP (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
Medpace Holdings, Inc. provides global pharmaceutical, biotechnology, and medical device clinical development services across North America, Europe, Asia, and beyond, from Phase I to Phase IV. The company offers plan design, central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance, regulatory submissions, and post-marketing support. It also provides bio-analytical lab work, clinical pharmacology, imaging, and ECG reading services. Founded in 1992, based in Cincinnati, Ohio.
Company score
- Sentiment
- -0.18
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.36
- Governance
- -0.64
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.03
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.10
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEODr. August James Troendle M.D.
- Founded1992
- Employees6,500
- Websitewww.medpace.com
Identifiers
- ISINUS58506Q1094
- FIGIBBG0065B7K59
- LEI549300H8TYEUVTW14A54
- CUSIP58506Q109
- CIK0001668397